US 11,958,848 B1
7-(4-((5-(2-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound
Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); Mai Mostafa Khalaf Ali, Al-Ahsa (SA); Antar Ahmed Abdelhamid Ahmed, Sohag (EG); and Amer A Amer, Sohag (EG)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERISTY, Al-Ahsa (SA)
Filed on Sep. 18, 2023, as Appl. No. 18/369,782.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 417/12 (2006.01); A61P 29/00 (2006.01)
CPC C07D 417/12 (2013.01) [A61P 29/00 (2018.01)] 2 Claims
 
1. A 7-(4-((5-(2-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid compound having the formula I:

OG Complex Work Unit Chemistry